Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1711)
  2. Journal Article (1446)
  3. Review (84)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (11)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3406)
  2. Solid Tumor Oncology Division (3406)
  3. GSK Faculty (1075)
  4. Department of Pathology and Laboratory Medicine (821)
  5. Hematology-Oncology Fellows (715)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (664)

More Groups

People
  1. Mark Kris (873)
  2. Alexander Drilon (639)
  3. Gregory Riely (606)
  4. Charles Rudin (497)
  5. Marc Ladanyi (419)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (126)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (704)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (159)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (90)

More Publications

Publishers
  1. American Society of Clinical Oncology (783)
  2. Elsevier Inc. (741)
  3. American Association for Cancer Research (387)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (80)

More Publishers

Results (3406)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of larotrectinib in non-primary central nervous system (CNS) TRK fusion cancer
    Meeting Abstract

    Drilon, A. E.; Xu, R. H.; van Tilburg, C. M.; Doz, F.; Tan, D. S. W.; Lin, J. J.; Geoerger, B.; Zwaan, C. M.; Lassen, U. N.; Italiano, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib as first-line treatment for patients (pts) with TRK fusion cancer: An updated analysis
    Meeting Abstract

    Hong, D. S.; Xu, R. H.; Shen, L.; Dierselhuis, M. P.; Orbach, D.; McDermott, R. S.; Italiano, A.; Tahara, M.; Bernard-Gauthier, V.; Neu, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
    Meeting Abstract

    Cabel, L.; An, J. A. R.; Kurtz, D.; Ross, D.; Dikoglu, E.; Chen, Y.; Murphy, K.; Szuhany, K.; Stowell, S. L.; Maloney, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Polygenic risk score associations with immune checkpoint inhibitors related endocrine toxicity
    Meeting Abstract

    Thorball, C. W.; Quandt, Z.; Saha, A.; Yao, L.; Midda, P.; Xu, Y.; Bejan, C. A.; Hodel, F.; Stravodimou, A.; Shearer-Kang, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Updated efficacy and safety from the phase II PHAROS study of encorafenib plus binimetinib in patients with BRAF V600E-mutant metastatic NSCLC (mNSCLC)
    Meeting Abstract

    Riely, G. J.; Ahn, M. J.; Clarke, J.; Dagogo-Jack, I.; Felip, E.; Gelsomino, F.; Goldman, J. W.; Hussein, M.; Johnson, M. L.; Morgensztern, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Benchmarking embedding aggregation methods in computational pathology: A clinical data perspective
    Conference Paper

    Chen, S.; Campanella, G.; Elmas, A.; Stock, A.; Zeng, J.; Polydorides, A. D.; Schoenfeld, A. J.; Huang, K. L.; Houldsworth, J.; Vanderbilt, C.; more...
    Journal Machine Learning Research (2024)

    Fulltext@MSK | Save
  • A phase I/II study of davutamig (REGN5093), a METxMET bispecific antibody, in patients with MET-altered, advanced non-small cell lung cancer (aNSCLC): Trial in progress update
    Meeting Abstract

    Ahn, M. J.; Cho, B.; Kim, T. M.; Han, J. Y.; Kim, C.; Shim, B.; Drilon, A.; Blumenschein, G.; Villaruz, L.; Gray, J. E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Randomized phase 3 study of first-line selpercatinib versus chemotherapy and pembrolizumab in RET fusion-positive NSCLC
    Meeting Abstract

    Loong, H.; Goto, K.; Solomon, B.; Park, K.; PeĢrol, M.; Arriola, E.; Novello, S.; Cheng, Y.; Ardizzoni, A.; Mak, M.; more...
    Oncology Research and Treatment (2024)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of larotrectinib in patients with TRK fusion primary central nervous system (CNS) tumors: An updated analysis
    Meeting Abstract

    Perreault, S.; Spano, J. P.; Nilsson, A.; Deyell, R. J.; Doz, F.; Geoerger, B.; Gumus, M.; Lassen, U. N.; Nysom, K.; Valero-Arrese, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save